514 Episodes

  1. S10 Ep9: FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL

    Published: 1/25/2024

  2. S10 Ep8: Lunning and Maddocks Talk Through Frontline MCL Management

    Published: 1/22/2024

  3. S10 Ep7: FDA Approval Insights: Nirogacestat in Progressing Desmoid Tumors Requiring Systemic Treatment

    Published: 1/15/2024

  4. S10 Ep6: Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

    Published: 1/11/2024

  5. S10 Ep5: Donington and Stiles Summarize NSCLC Resectability Parameters and Multidisciplinary Management

    Published: 1/8/2024

  6. S10 Ep4: FDA Approval Insights: Capivasertib Plus Fulvestrant in Advanced HR+/HER2- Breast Cancer With PIK3CA, AKT1, or PTEN Alterations

    Published: 1/4/2024

  7. S10 Ep3: Santos Summarizes Key Updates From EMPOWER-Lung 1 and EMPOWER-Lung 3 With Cemiplimab in NSCLC

    Published: 1/1/2024

  8. S10 Ep2: Jabbour Reports Top Takeaways From ASH 2023 of Olverembatinib in CML and ALL

    Published: 12/28/2023

  9. S10 Ep1: Eskander Emphasizes the Importance of Inclusivity and Accessibility in Oncology Clinical Trials

    Published: 12/25/2023

  10. S9 Ep50: Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

    Published: 12/21/2023

  11. S9 Ep49: Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors

    Published: 12/18/2023

  12. S9 Ep48: Donington and Stiles Describe the Surgical Implications of Lung Cancer Treatment Evolutions

    Published: 12/11/2023

  13. S9 Ep47: Abdou Spotlights Factors Influencing ADC Treatment Selection in Breast Cancer

    Published: 12/7/2023

  14. S9 Ep46: FDA Approval Insights: Toripalimab in Recurrent/Metastatic Nasopharyngeal Carcinoma

    Published: 12/4/2023

  15. S9 Ep45: Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma

    Published: 11/30/2023

  16. S9 Ep44: Dumbrava Details Ongoing Research With PC14586 in p53 Y220C–Mutated Advanced Solid Tumors

    Published: 11/23/2023

  17. S9 Ep43: FDA Approval Insights: Ivosidenib in R/R IDH1+ Myelodysplastic Syndrome

    Published: 11/20/2023

  18. S9 Ep42: Halmos Highlights Evaluation of the EGFR Inhibitor BDTX-1535 in NSCLC

    Published: 11/16/2023

  19. S9 Ep41: Feigin Discusses the Association Between Benzodiazepines and Pancreatic Cancer Outcomes

    Published: 11/13/2023

  20. S9 Ep40: Khouri Highlights the Ongoing AFFIRM-AL Trial in AL Amyloidosis

    Published: 11/9/2023

14 / 26